Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
13.39
+0.59 (4.61%)
Dec 3, 2025, 4:00 PM EST - Market closed

Alto Neuroscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
416114---
Enterprise Value
312-52---
Last Close Price
12.804.23---
PB Ratio
3.120.75---
P/TBV Ratio
3.800.75---
Debt / Equity Ratio
0.230.110.140.28-
Quick Ratio
15.2416.8114.718.7615.17
Current Ratio
15.4216.9215.228.8515.30
Return on Equity (ROE)
-45.01%-55.19%-67.95%-88.40%-
Return on Assets (ROA)
-24.48%-32.46%-34.38%-45.81%-
Return on Capital (ROIC)
-26.11%-34.37%-37.30%-50.29%-
Return on Capital Employed (ROCE)
-48.10%-41.00%-46.70%-64.50%-44.70%
Earnings Yield
-14.68%-53.85%---
FCF Yield
-12.69%-43.39%---
Buyback Yield / Dilution
-43.22%-559.39%-8.27%-42.78%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q